Skip to main content
Clinical Trials/NCT05089318
NCT05089318CompletedNot Applicable

Curcuminoids and Boswellia Serrata Extracts Combination Decreases Hand Joint Discomfort : Results From a Belgian Real-Life Experience

Tilman S.A.1 site in 1 country239 target enrollmentStarted: September 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
239
Locations
1
Primary Endpoint
Pain using a Numerical Rating Scale (NRS)

Study Overview

Brief Summary

The purpose of this study is to evaluate the effect of curcuminoids and Boswellia serrata extracts combination (Flexofytol PLUS) in support to standard treatments during a 12-weeks period on hand pain on people with chronic hand joint discomfort.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
45 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Older dan 45 years old,
  • With hand joint chronic discomfort,
  • Regularly uses of paracetamol or NSAIDs to manage pain,
  • Painful symptoms must have been present for more than 6 months,
  • The patient assesses their pain on a visual pain scale and must be greater than 4 out of 10 over the last 48 hours.

Exclusion Criteria

  • Related to previous and associated treatments:
  • Corticosteroids injection in the 3 previous months, whatever the joint concerned,
  • Use of Slow-acting drugs for OA and/or dietary supplements taken within less than 6 months prior to the study (ex: chondroitin sulfate, diacerein, soy and avocado unsaponifiables, oxaceprol, granions de cuivre, glucosamine, phytotherapy or homeopathy for hand joint discomfort..),
  • Anticoagulant (coumarinic) treatment and heparin,
  • General corticotherapy in the 3 previous months,
  • Contraindication to paracetamol, curcumin, boswellia and NSAID's.
  • Related to associated pathologies:
  • Patient suffering from serious associated illness (liver failure, kidney failure, non-controlled cardiovascular diseases...),
  • The patient has rheumatoid arthritis or gout,
  • The patient has a bile obstruction.
  • Related to patient:
  • Pregnant or breastfeeding women.

Outcomes

Primary Outcomes

Pain using a Numerical Rating Scale (NRS)

Time Frame: 84 days

Change from baseline of the mean pain over the last 48 hours evaluated by the patient on a 0 to 10 scale ( 0= no pain and 10=maximal pain)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Tilman S.A.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials